TALi Digital Raises $800,000 to Accelerate Commercialisation of Attention Tools
TALi Digital has successfully raised $800,000 through a private placement to fuel the commercialisation of its digital health products aimed at enhancing childhood cognitive attention.
- Raised $800,000 via private placement
- Funds targeted at product commercialisation and partnerships
- Focus on early childhood cognitive attention solutions
- Products include DETECT®, TRAIN®, and ReadyAttentionGo!
- Plans to expand offerings for ADHD and ASD
Funding Boost for Digital Health Innovation
TALi Digital Limited (ASX, TD1) has announced the completion of a private placement that raised $800,000 before costs. The capital injection comes as the company intensifies efforts to commercialise its suite of digital health products designed to improve cognitive attention in early childhood.
The placement attracted sophisticated and professional investors, signaling confidence in TALi’s vision and technology. The funds will primarily support the advancement of global and domestic partnership initiatives, which are critical to scaling the company’s reach and impact.
Innovative Solutions Targeting Childhood Attention
TALi Digital’s platform technology underpins its flagship programs, DETECT®, an evidence-based screening tool, and TRAIN® alongside ReadyAttentionGo!, which are play-based training modules. These products are designed to complement existing therapies and provide early intervention for attention and concentration challenges, positioning TALi at the forefront of digital cognitive care.
With a focus on personalised digital experiences, TALi aims to address conditions such as Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD) through continuous innovation and product development. This strategic direction aligns with growing demand for accessible, technology-driven healthcare solutions.
Looking Ahead
Chair Mark Simari highlighted the importance of the capital raise in accelerating TALi’s commercialisation pathway and expanding its partnership network. While the announcement does not detail specific timelines or a breakdown of fund allocation, the injection of capital is a clear vote of confidence in the company’s growth prospects.
Investors will be watching closely for updates on partnership agreements and product launches that could validate TALi’s market positioning and drive shareholder value.
Bottom Line?
TALi Digital’s fresh capital positions it to advance its niche in digital cognitive health, but execution on partnerships will be key.
Questions in the middle?
- What specific partnerships are in the pipeline following the placement?
- How soon can TALi expect revenue growth from commercialised products?
- What milestones will indicate successful market adoption of their ADHD and ASD solutions?
